Laura Llorente Sanz

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 8

Top Topics

Peritoneal Dialysis

Respiratory Syndrome Coronavirus

Ejection Fraction

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Javier David Benitez Fuentes, Alicia de Luna Aguilar, Alejandro Francisco Jimenez Ortega, Paloma Flores Navarro, Jorge Bartolomé Arcilla, Elvira Baos Muñoz, Alberto Delgado-Iribarren, Sara Gil Useros, Ignacio Martinez Capella, Laura Llorente Sanz, Macarena Torrego-Ellacuría, Pedro Pérez Segura
Adverse drug reactions to the three doses of the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) mRNA-1273 vaccine in a cohort of cancer patients under active treatment of a tertiary hospital in Madrid, Spain. F1000Research 11 (2022)
Javier David Benitez Fuentes, Alicia de Luna Aguilar, Alejandro Francisco Jimenez Ortega, Paloma Flores Navarro, Jorge Bartolomé Arcilla, Elvira Baos Muñoz, Alberto Delgado-Iribarren, Sara Gil Useros, Ignacio Martinez Capella, Laura Llorente Sanz, Macarena Torrego-Ellacuría, Pedro Pérez Segura
Adverse drug reactions to the three doses of the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) mRNA-1273 vaccine in a cohort of cancer patients under active treatment of a tertiary hospital in Madrid, Spain. F1000Research 11 (2022)
Javier David Benitez Fuentes, Alicia de Luna Aguilar, Alejandro Francisco Jimenez Ortega, Paloma Flores Navarro, Jorge Bartolomé Arcilla, Elvira Baos Muñoz, Alberto Delgado-Iribarren, Sara Gil Useros, Ignacio Martinez Capella, Laura Llorente Sanz, Macarena Torrego-Ellacuría, Pedro Pérez Segura
Adverse drug reactions to the three doses of the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) mRNA-1273 vaccine in a cohort of cancer patients under active treatment of a tertiary hospital in Madrid, Spain. F1000Research 11 (2022)
Javier David Benitez Fuentes, Alicia de Luna Aguilar, Alejandro Francisco Jimenez Ortega, Paloma Flores Navarro, Jorge Bartolomé Arcilla, Elvira Baos Muñoz, Alberto Delgado-Iribarren, Sara Gil Useros, Ignacio Martinez Capella, Laura Llorente Sanz, Macarena Torrego-Ellacuría, Pedro Pérez Segura
Adverse drug reactions to the three doses of the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) mRNA-1273 vaccine in a cohort of cancer patients under active treatment of a tertiary hospital in Madrid, Spain. F1000Research 11 (2022)
Javier David Benitez Fuentes, Alicia de Luna Aguilar, Alejandro Francisco Jimenez Ortega, Paloma Flores Navarro, Jorge Bartolomé Arcilla, Elvira Baos Muñoz, Alberto Delgado-Iribarren, Sara Gil Useros, Ignacio Martinez Capella, Laura Llorente Sanz, Macarena Torrego-Ellacuría, Pedro Pérez Segura
Adverse drug reactions to the three doses of the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) mRNA-1273 vaccine in a cohort of cancer patients under active treatment of a tertiary hospital in Madrid, Spain. F1000Research 11 (2022)
Javier David Benitez Fuentes, Alicia de Luna Aguilar, Alejandro Francisco Jimenez Ortega, Paloma Flores Navarro, Jorge Bartolomé Arcilla, Elvira Baos Muñoz, Alberto Delgado-Iribarren, Sara Gil Useros, Ignacio Martinez Capella, Laura Llorente Sanz, Macarena Torrego-Ellacuría, Pedro Pérez Segura
Adverse drug reactions to the three doses of the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) mRNA-1273 vaccine in a cohort of cancer patients under active treatment of a tertiary hospital in Madrid, Spain. F1000Research 11 (2022)
Javier David Benitez Fuentes, Alicia de Luna Aguilar, Alejandro Francisco Jimenez Ortega, Paloma Flores Navarro, Jorge Bartolomé Arcilla, Elvira Baos Muñoz, Alberto Delgado-Iribarren, Sara Gil Useros, Ignacio Martinez Capella, Laura Llorente Sanz, Macarena Torrego-Ellacuría, Pedro Pérez Segura
Adverse drug reactions to the three doses of the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) mRNA-1273 vaccine in a cohort of cancer patients under active treatment of a tertiary hospital in Madrid, Spain. F1000Research 11 (2022)
Javier David Benitez Fuentes, Alicia de Luna Aguilar, Alejandro Francisco Jimenez Ortega, Paloma Flores Navarro, Jorge Bartolomé Arcilla, Elvira Baos Muñoz, Alberto Delgado-Iribarren, Sara Gil Useros, Ignacio Martinez Capella, Laura Llorente Sanz, Macarena Torrego-Ellacuría, Pedro Pérez Segura
Adverse drug reactions to the three doses of the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) mRNA-1273 vaccine in a cohort of cancer patients under active treatment of a tertiary hospital in Madrid, Spain. F1000Research 11 (2022)